StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Rating) in a report published on Wednesday. The firm issued a hold rating on the stock. Can-Fite BioPharma Trading Down 1.1 % Shares of NYSE CANF opened at $2.31 on Wednesday. Can-Fite BioPharma has a 52 week low of $1.52 and a 52 week […]
Shares of Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF – Get Rating) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $2.70 and traded as low as $2.08. Can-Fite BioPharma shares last traded at $2.14, with a volume of 6,690 shares traded. Analysts Set New Price […]
StockNews.com started coverage on shares of Can-Fite BioPharma (NYSEAMERICAN:CANF – Get Rating) in a research note released on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $34.00 price objective on shares of Can-Fite BioPharma in a report on Monday, March […]
StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSEAMERICAN:CANF – Get Rating) in a research report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $34.00 price objective on shares of Can-Fite BioPharma in a research note on Monday, […]
StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Rating) in a report published on Tuesday morning. The firm issued a hold rating on the stock. Can-Fite BioPharma Price Performance Shares of CANF opened at $2.10 on Tuesday. The stock has a market cap of $7.43 million, a price-to-earnings ratio of -0.57 and […]